Preparation of manganese-based perovskite nanoparticles using a reverse microemulsion method: Biomedical applications

12Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.
Get full text

Abstract

In this study, La0.7Sr0.3Mn0.98Ti0.02O3 (LSMTO) nanoparticles with a perovskite structure and an average particle size of 23.5 nm were synthesized using a reverse microemulsion method. In this method, cetyltrimethylammonium bromide (CTAB) was used as a surfactant, 1-butanol as a co-surfactant, n-hexane as a continuous oil phase, and an aqueous solution containing metal cations or precipitating agent as a dispersed aqueous phase. The aqueous nanodroplets of microemulsions were used for the formation of perovskite precursor. The obtained precursor was then calcined at 700°C for 4 h to convert the precursor to the perovskite phase. In addition, the heating ability of the LSMTO nanoparticles was evaluated under a safe alternating magnetic field used in magnetic hyperthermia therapy. The results showed the fast magneto-temperature response of the prepared sample with sufficient heat loss at the therapeutic temperature range, indicating the LSMTO nanoparticles can be used as a self-regulated heating agent in the magnetic hyperthermia therapy.

Cite

CITATION STYLE

APA

Soleymani, M., & Edrissi, M. (2016). Preparation of manganese-based perovskite nanoparticles using a reverse microemulsion method: Biomedical applications. Bulletin of Materials Science, 39(2), 487–490. https://doi.org/10.1007/s12034-016-1164-4

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free